Yi Lan-Fen, Wen Hong-Xia, Huang Sui, Qiu Mei, Zhang Jing-Yang, Cao Xiao-Xiao
Department of Electrocardiogram, Wuhan Medical Health Care Center for Women and Children/Wuhan Children's Hospital/Wuhan Maternal and Child Health Care Hospital, Wuhan 430016, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2016 Apr;18(4):345-9. doi: 10.7499/j.issn.1008-8830.2016.04.013.
To investigate the effects of oral administration of low-dose propranolol on heart rate variability (HRV), acceleration capacity (AC), deceleration capacity (DC), and cardiac conduction in the treatment of infantile hemangioma.
A total of 118 infants with hemangioma (≤1 year) were enrolled, and 24-hour ambulatory electrocardiography was performed before oral administration of low-dose propranolol and after one month of administration. The changes in time-domain indices [standard deviation of all normal sinus RR intervals (SDNN), standard deviation of all mean 5-minute RR intervals (SDANN), root mean squared successive difference (RMSSD), and percentage of successive normal sinus RR intervals >50 ms (PNN50)] and frequency-domain indices [low frequency (LF) and high frequency (HF)] for HRV, AC, and DC were observed, as well as abnormalities in cardiac conduction and other aspects after administration of propranolol.
After administration of propranolol, the infants had significantly increased SDNN, RMSSD, LF, HF, and PNN50 (P<0.01), and significantly reduced AC, mean heart rate (HR) and minimum HR (P<0.01). The 24-hour ambulatory electrocardiographic findings showed a nonsignificantly higher abnormal rate after administration of propranolol.
In the treatment of infantile hemangioma, propranolol can inhibit the activity of sympathetic nerve and block cardiac conduction, but without any serious adverse effect.
探讨口服低剂量普萘洛尔对婴儿血管瘤治疗中心率变异性(HRV)、加速能力(AC)、减速能力(DC)及心脏传导的影响。
共纳入118例年龄≤1岁的血管瘤婴儿,在口服低剂量普萘洛尔前及给药1个月后进行24小时动态心电图检查。观察HRV、AC和DC的时域指标[所有正常窦性RR间期的标准差(SDNN)、所有平均5分钟RR间期的标准差(SDANN)、相邻RR间期差值的均方根(RMSSD)以及相邻正常窦性RR间期>50 ms的百分比(PNN50)]和频域指标[低频(LF)和高频(HF)],以及普萘洛尔给药后心脏传导和其他方面的异常情况。
普萘洛尔给药后,婴儿的SDNN、RMSSD、LF、HF和PNN50显著增加(P<0.01),AC、平均心率(HR)和最低HR显著降低(P<0.01)。24小时动态心电图检查结果显示,普萘洛尔给药后异常率略有升高,但差异无统计学意义。
在婴儿血管瘤治疗中,普萘洛尔可抑制交感神经活性并阻滞心脏传导,但无严重不良反应。